Aminoterminal B-Type Natriuretic Peptide (NT-proBNP) in End-Stage Renal Failure Patients on Regular Hemodialysis: Does It Have Diagnostic and Prognostic Implications?
Nephron Clinical Practice · 05.02.2009 · 111 (3) · c182-c188
DOI: 10.1159/000199458 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Nephron Clinical Practice, online erschienen am 05.02.2009. Verfasst von Joana Pimenta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hospital S. João, Porto, Portugal. joanapimenta@clix.pt. Hauptthemen laut MEDLINE: Renal Dialysis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background
Amino-terminal B-type natriuretic peptide (NT-proBNP) quantification is a useful cardiovascular diagnostic and prognostic test. In renal failure its use may have constraints, as it depends on renal clearance. We aimed to evaluate the clinical usefulness of NT-proBNP in hemodialysis (HD) patients.
Methods
We measured NT-proBNP levels in 44 patients before and after a regular high-flux HD. Cardiac parameters were evaluated by echocardiography. Patients were followed up for 656.5 ± 476.4 days for the occurrence of hospital admission or death.
Results
NT-proBNP levels decreased after HD (p < 0.0001) without correlation with ultrafiltration volume, Kt/V index, weight decrease or pulse pressure decrease. Pre- and post-HD NT-proBNP were similar in patients with and without left ventricular hypertrophy. Pre-HD levels were not significantly associated with prognosis, probably due to a type 2 error; post-HD NT- proBNP and NT-proBNP reduction ratio (RR) were predictive of the outcome by Kaplan-Meier analysis, but only RR remained associated with prognosis on multivariate regression analysis (hazard ratio 0.96; 95% confidence interval 0.93–0.99).
Conclusion
Our results do not support the use of NT-proBNP in the diagnosis of left ventricular hypertrophy or volume status in HD patients, but suggest its utility in prognostic stratification. HD-related variation in NT-proBNP was associated with prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Internal Medicine Department, Hospital S. João, Porto, Portugal. joanapimenta@clix.pt
Zitieren
APA
Pimenta, J., Sampaio, F., Martins, P., Carvalho, B., Rocha-Gonçalves, F., Ferreira, A., & Bettencourt, P. (2009). Aminoterminal B-Type Natriuretic Peptide (NT-proBNP) in End-Stage Renal Failure Patients on Regular Hemodialysis: Does It Have Diagnostic and Prognostic Implications?. Nephron Clinical Practice, 111(3), c182-c188. https://doi.org/10.1159/000199458
Vancouver
Pimenta J, Sampaio F, Martins P, Carvalho B, Rocha-Gonçalves F, Ferreira A, et al. Aminoterminal B-Type Natriuretic Peptide (NT-proBNP) in End-Stage Renal Failure Patients on Regular Hemodialysis: Does It Have Diagnostic and Prognostic Implications?. Nephron Clinical Practice. 2009;111(3):c182-c188. doi:10.1159/000199458
BibTeX
@article{Pimenta2009,
author = {Pimenta, Joana and Sampaio, Francisco and Martins, Patrícia and Carvalho, Berta and Rocha-Gonçalves, Francisco and Ferreira, António and Bettencourt, Paulo},
title = {Aminoterminal B-Type Natriuretic Peptide (NT-proBNP) in End-Stage Renal Failure Patients on Regular Hemodialysis: Does It Have Diagnostic and Prognostic Implications?},
journal = {Nephron Clinical Practice},
year = {2009},
volume = {111},
number = {3},
pages = {c182--c188},
doi = {10.1159/000199458}
}
EUVIMED